Medical Devices Startups

Brink Biologics provides NK-92 cell lines and assay panels for antibody-dependent cell-mediated cytotoxicity (ADCC) testing in therapeutic antibody development. The company offers proprietary Neukopanel cell lines and related services to pharmaceutical and biotechnology companies developing cancer and immunotherapy treatments.

1 investor

Britescope manufactures a portable video-nasopharyngoscope for endoscopic diagnostic procedures in ENT (ear, nose, throat) medicine, featuring a detachable handheld display unit and insertion module. The device targets healthcare specialists seeking affordable, portable video-endoscopy with simplified reprocessing and reduced equipment footprint compared to traditional endoscopic towers.

1 investor

Briteseed develops hyperspectral imaging technology integrated into laparoscopic and robotic surgical instruments to provide real-time visualization of critical anatomical structures during surgery. The company produces a suite of surgical tools including energy, stapler, and dissection instruments that display information on existing operating room monitors to improve surgical safety and outcomes.

1 investor

Broadwing Bio develops antibody-based therapies targeting genetically validated ophthalmology conditions, particularly geographic atrophy and glaucoma, to preserve vision and prevent blindness. The company builds on naturally occurring genetic variants to create novel treatments for ocular diseases.

1 investor

Broomx provides immersive media and interactive applications that enable personalized therapeutic and experiential sessions. The company uses patented technology to deliver 360° content and virtual reality applications in shared physical spaces without requiring headsets.

1 investor

Bruker Cellular Analysis develops technologies for live single-cell biology research, combining optofluidics, live single-cell imaging, functional cell biology, and multiomic data to study cellular function and molecular mechanisms. It serves scientists in academia, biotech and pharmaceutical companies, and contract research organizations, supporting work in cell therapy, therapeutic antibody discovery, vaccine development, and cell line development.

1 investor

BTB Therapeutics develops a non-opioid analgesic aimed at addressing the opioid crisis, along with a pipeline of RNA-modifying compounds for rare genetic diseases and to enhance cancer immunotherapy. The company is based on transcriptomics drug discovery programs from Kyoto University, with a US parent and an operating subsidiary in Kyoto, Japan.

1 investor

bTECH develops the Halcyon SMART Patch, a wound care device that uses far-infrared wavelengths to promote tissue healing and prevent amputations in patients with chronic non-healing wounds. The company also provides engineering support and data analytics services for research, product development, and commercialization in wound care and regenerative medicine.

1 investor

Button is an online supplier of medical-grade supplies sourced directly from vetted manufacturers and distributors, offering bulk pricing and fast shipping. It serves medical practices and clinics looking to keep supplies stocked.

1 investor

Buck Surgical develops surgical technologies aimed at improving outcomes for complex procedures and expanding patient access to reconstructive and limb-preserving treatments. The company focuses on new anastomotic and surgical devices for plastic and reconstructive surgery.

1 investor

Buckeye Hospice Care provides physical, occupational, and speech therapy services as part of hospice care, focusing on patient safety, comfort, and quality of life.

1 investor

BÜHLMANN Laboratories is a life science company based in Switzerland.

1 investor

A healthcare technology company combining clinical leadership with logistics expertise to improve healthcare access globally, with particular focus on remote and underserved regions.

1 investor

Bumame operates health clinics in Indonesia offering diagnostic services including HPV screening, vaccination, and cervical cancer self-testing. The company provides medical services designed to meet local healthcare needs with international standards.

1 investor

Vanderbilt Health researchers, supported by Eli Lilly funding, are developing an AI triage agent embedded in electronic health record systems to accelerate patient referrals and treatment initiation for Alzheimer's disease. The tool is designed to be transferable across health systems and aims to reduce delays in the care pathway from diagnosis to first infusion of monoclonal antibody therapies.

1 investor

Bykart develops a suite of software solutions for healthcare providers to improve patient care and streamline clinic operations and internal communications. The company offers both standalone products and integrated solutions designed for health systems.

1 investor

Byteflies provides remote vital signs monitoring solutions using certified medical devices, delivering patient data from the home into providers' workflows and handling device logistics and system integration. It serves hospitals, life sciences and medtech companies, and academic researchers for telemonitoring, patient support programs, and clinical trials.

1 investor

C the Signs develops AI-powered tools for early cancer detection using real-time data and evidence-based pathways. The platform is designed for healthcare systems and clinicians to improve patient outcomes through earlier diagnosis across all populations.

1 investor

C-mo develops an automated wearable device that records and analyzes cough patterns in real-time for continuous patient monitoring. The system measures cough frequency and intensity while protecting patient privacy, serving healthcare providers and clinical researchers studying respiratory conditions.

1 investor

Cadence Health Ventures is a venture capital firm focused on building and backing medical technology companies, with over 20 years of experience investing across clinical, regulatory, and commercial inflection points to drive medtech innovation and exits.

1 investor

Cadent Therapeutics was a Cambridge, Massachusetts-based neuroscience company developing clinical-stage therapies for neuropsychiatric disorders including schizophrenia, movement disorders, and treatment-resistant depression. The company was acquired by Novartis in 2021.

1 investor

Caeli Vascular develops a medical device platform for the treatment of venous thrombotic disease, specifically designed to remove blood clots in deep vein thrombosis cases. The company targets physicians and healthcare institutions seeking to improve patient outcomes in interventional vascular care.

1 investor

Cagent Vascular develops endovascular medical devices, including the Serranator PTA Serration Balloon Catheter, for the treatment of vascular disease. The company serves vascular surgeons and interventionalists in the medical device industry.

1 investor

Caire Health develops AI software that analyzes medical imaging to assist emergency department teams in rapidly identifying critical conditions and triaging patients for immediate treatment.

1 investor